Melbourne-based Amplia Therapeutics, a company focused on developing targeted cancer therapies, has released updated data from its ongoing ACCENT clinical trial, and its share price more than doubled in response. …
Australian biotech surges in response to trial suggesting a new hope in the fight against pancreatic cancer
March 24, 2026 Latest NewsBioPharmaNews of the DayAustralian Biotech
Latest Video
New Stories
-
TGA approves GSK's six‑monthly treatment for severe eosinophilic asthma and nasal polyps
July 28, 2026 - - Latest News -
Long-COVID still reshaping life for medically vulnerable Australians
July 28, 2026 - - Latest News -
Australians with rare diseases still waiting too long for access to treatments
July 28, 2026 - - Latest News -
New research shows chronic pain is widespread and undertreated in Australia
July 28, 2026 - - Latest News -
Bellberry announces new appointment to board of directors
July 27, 2026 - - Latest News -
The power of this commitment might be as a comparison of national intent
July 27, 2026 - - Latest News -
New AI platform aims to give patients a strong voice in medicines funding
July 27, 2026 - - Latest News